NUCHIDO TIME+ IS SUPPORTED BY
CLINICAL RESEARCH
NUCHIDO TIME+ IS SUPPORTED BY
CLINICAL RESEARCH
A randomised, double-blinded, placebo-controlled crossover clinical trial was performed on the Nuchido TIME+ dietary supplement. Participants were male and female, aged 20-80 years old.
Our patented formulation significantly increased NAD+ after 28 days of supplementation.
Declining levels of the NAD+ recycling enzyme NAMPT is the leading cause of age-related NAD+ decline.
Nuchido TIME+ was found to increase levels of the NAMPT enzyme after 28 days of supplementation.
SIRT1 is a NAD+-dependent enzyme that coordinates many of the health-promoting effects of NAD+.
Nuchido TIME+ was found to significantly increase SIRT1 after 28 days of supplementation.
Your biological age is how old you are on the inside.
Nuchido TIME+ was found to reduce biological age by an average of 1.26 years after 28 days of supplementation.
The GlycanAge biological age test is available as a consumer kit allowing customers to test the efficacy of Nuchido TIME+.
Inflammation is a leading cause of cellular aging.
Nuchido TIME+ was found to reduce inflammatory factors (cytokines IL-2, IL-5 and IL-23) after 28 days of supplementation.
Glycated serum proteins are precursors to advanced glycation end-products (AGES) which are highly correlated with ageing and multiple age-related issues.
Nuchido TIME+ was found to decrease glycated serum protein after 28 days of supplementation.